All lobbying filings
TIBER CREEK GROUP
Lobbying for ACADIA PHARMACEUTICALS, INC. · Biopharmaceutical company.
Filing
Q1 report
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 18, 2026
Income
$80,000.00
What the client paid this registrant for the period.
Client based in
California
Government bodies contacted
2
Lobbying activity
1
Issues related to rare disease treatments, including rare disease research incentives; Issues related to the Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to drug pricing reforms.